secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001654954-24-005476
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve extension of long-term incentive plan to 2034; re-elect two directors
--------------------------------------------------------------------------------

- Stockholders approved extending the 2014 Long-Term Incentive Plan term to March 31, 2034.
- Re-elected Kirk Michel (12.65M votes for) and Dov Perlysky (7.55M votes for) as Class II directors until 2027.
- Crowe PR PSC ratified as independent auditor for fiscal year ending Oct 31, 2024 (14.36M for, 1.5K against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/0001654954-24-005476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495424005476/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-005476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer